Business
Sareum to Present at BIO-Euro
Sareum to Present at BIO-Euro.
About this update from Sareum Holdings Plc
[{"type":"text","content":"\n RNS Number : 6860B Sareum Holdings PLC 02 November 2009 \n\n\n\n\n(AIM: SAR)\n\n\n2 November 2009\n\n\n\n\n\nSAREUM HOLDINGS PLC(\"Sareum\" or the \"Company\") \nSareum to Present at BIO-Europe 2009\nSareum (AIM: SAR), the specialist cancer drug discovery business, is pleased to announce that Dr Tim Mitchell, CEO, will present Sareum's cancer drug discovery pipeline at BIO-Europe 2009 later today.\nBIO-Europe, being held this year in Vienna, Austria, is Europe's largest biotechnology partnering event. Dr Mitchell's presentation is part of the UK Showcase, an International Seminar introduced by UK Trade & Investment.\n\n\n\n\n\nSareum Holdings plc\n\n\n\n\n\n\n\nTim Mitchell\n\n\n01223 497 700\n\n\n\n\n\n\n\n\n\n\n\n\nMerchant John East Securities Limited\n\n\n\n\nSimon Clements/Bidhi Bhoma\n\n\n020 7628 2200\n\n\n\n\n\n\n\n\n\n\n\n\nHybridan LLP\n\n\n\n\n\n\n\nClaire Noyce/Stephen Austin\n\n\n020 3159 5085\n\n\n\n\nNotes for editors: \nAbout Sareum Holdings plc\n\nSareum is a drug discovery company, headquartered in Cambridge UK, that is focused on producing targeted small molecule therapeutics to address unmet medical needs, primarily in cancer.\n\nSareum aims to successfully deliver drug candidates for licensing to pharmaceutical and biotechnology companies at the pre-clinical or early clinical trials stage.\n\nSareum Holdings plc joined the AIM market of the London Stock Exchange in October 2004, trading under the symbol SAR. For further information, please visit www.sareum.co.uk\n\nThis information is provided by RNSThe company news service from the London Stock Exchange END NRALBLFXKBBXFBF\n ","length":4689,"tagName":"div"}]